Twenty women were given a bolus induction of propofol 2.0 mg.kg−1 for elective caesarean section. Induction to delivery times ranged from five to fourteen minutes. At delivery the maternal venous (MV) concentrations of propofol ranged from 0.53 to 1.48 μg.ml−1 umbilical vein (UV) 0.39 to 1.4 μg.ml−1 and umbilical artery (UA) 0.34 to 0.68 μg.ml−1 MV propofol concentrations were always higher than corresponding UV concentrations. The mean (95% confidence interval) UV/MV ratio was 0.65 (0.56–0.74) and the mean UA/UV ratio was 1.07 (0.99–1.15). Neither ratio was shown to be correlated with induction to delivery time. Distribution of propofol is rapid across the placenta and in the fetus. Apgar scores were higher with shorter incision to delivery times but were not correlated to umbilical levels of propofol.
GinT., GregoryM.A., ChanK., BuckleyT., OhT.E.Pharmacokinetics of propofol in women undergoing elective caesarean section. Br J Anaesth1990; (in press).
2.
CellenoD., CapognaG., TomassettiM., CostantinoP., Di FeoG., NisiniR.Neurobehavioural effects of propofol on the neonate following elective caesarean section. Br J Anaesth1989; 62: 649–654.
3.
DaillandP., LirzinJ.D., CockshottI.D., JorrotJ.C., ConseillerC.Placental transfer and neonatal effects of propofol administered during cesarean section. Anesthesiology1987; 67(3A): A454.
4.
CouperJ.L., LombardT.P.Comparison of propofol (Diprivan) with thiopentone as induction agent for elective caesarean section. Can J Anaesth1988; 35(3S): S132.
5.
MackenzieN., GrantI.S.Comparison of the new emulsion formulation of propofol with methohexitone and thiopentone for induction of anaesthesia in day cases. Br J Anaesth1985; 57: 725–731.
6.
PlummerG.F.Improved method for the determination of propofol in blood by high performance liquid chromatography with fluorescence detection. J Chromatogr1987; 421: 171–176.
SantosA.C., FinsterM., PedersenH., MorishimaH.O.Perinatal pharmacology of anaesthetic agents. Clinics in Anaesthesiology1986; 4: 67–79.
9.
JuchauM.R.Drug biotransformation in the placenta. Pharmacol Ther1980; 8: 501–524.
10.
HillM.D., AbramsonF.P.The significance of plasma protein binding on the fetal/maternal distribution of drugs at steady state. Clin Pharmacokinet1988; 14: 156–170.
11.
McKechnieF.B., ConverseJ.G.Placental transmission of thiopental. Am J Obstet Gynecol1955; 70: 639–644.
12.
FinsterM., MarkL.C., MorishimaH.O., MoyaF., PerelJ.M., JamesL.S., DaytonP.G.Plasma thiopental concentrations in the newborn following delivery under thiopental-nitrous oxide anesthesia. Am J Obstet Gynecol1966; 95: 621–629.
SchüttlerJ., StoeckelH., SchwildenH.Pharmacokinetic and pharmacodynamic modelling of propofol (‘Diprivan’) in volunteers and surgical patients. Postgrad Med J1985; 61(Suppl 3): 53–54.
15.
ShaferA., DozeV.A., ShaferS.L., WhiteP.F.Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology1988; 69: 348–356.
16.
BesunderJ.B., ReedM.D., BlumerJ.L.Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part I). Clin Pharmacokinet1988; 14: 189–216.
17.
DattaS., OstheimerG.W., WeissJ.B., BrownW.V., AlperM.H.Neonatal effect of prolonged anesthetic induction for cesarean section. Obstet Gynecol1981; 58: 331–335.
18.
LittleB., ChangeT., ChucotL.Study of ketamine as an obstetric anesthetic agent. Am J Obstet Gynecol1972; 113: 247–260.
19.
EllingsonA., HaramK., SagenN., SolheimE.Transplacental passage of ketamine after intravenous administration. Acta Anaesthesiol Scand1977; 21: 41–44.
20.
MorganD.J., BlackmanG.L., PaullJ.D., WolfL.J.Pharmacokinetics and plasma binding of thiopental. II: Studies at cesarean section. Anesthesiology1981; 54: 474–480.
21.
Heslop ChristensenJ., AndreasenF., JansenJ.A.Pharmacokinetics of thiopental in caesarian section. Acta Anaesthesiol Scand1981; 25: 174–179.
22.
SchepensP., HeyndrickxA.Placental transfer of thiopental. Eur J Toxicol1975; 8: 87–93.
